Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

NIPER campus proposal yet to see the light of the day

researchsnappy by researchsnappy
December 25, 2019
in Healthcare Research
0
NIPER campus proposal yet to see the light of the day
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

The proposed establishment of the campus of National Institute of Pharmaceutical Education and Research (NIPER) in Visakhapatnam has hit a roadblock due to lack of coordination between officials the State and Central governments even as the announcement sanctioning it was made in early 2016.

While the Centre blames it on the State for failure to allot suitable land, sources in the APIIC say they had already identified land near Jawaharlal Nehru Pharma City, Parawada. During his recent visit, Rajya Sabha member Y.S. Chowdhary said the Centre had not received a formal proposal from the State government.

The pharma industry, which has high expectation to make North Andhra a hub for active pharmaceutical ingredients and cancer research, has decided to step up lobbying for the NIPER campus to overcome shortage of high-end manpower.

“The proposal is long-pending and we will benefit a lot if it is taken up on a fast-track basis,” JNPC CEO Lal Krishna told The Hindu.

North Andhra, home to prominent pharma units such as Aurobindo Pharma, Reddy’s Lab, Divi’s, Eisai, Hospira and Mylan has an estimated turnover of over ₹30,000 crore. JNPC has no further scope for expansion and there is a growing demand to take up work on a second pharma city in the Public Private Partnership mode.

NIPER is a premier national-level institute with recognition by the industry as a centre of excellence for advanced studies and research in pharmaceutical education. It is an autonomous institute, which functions under the administrative control of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. It aims to promote leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa.

“We want both the State and the Centre take the initiative to make NIPER operational from the next academic year,” Vizag Development Forum vice-president O. Naresh Kumar said.

You have reached your limit for free articles this month.

Register to The Hindu for free and get unlimited access for 30 days.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Previous Post

How employers can keep holiday parties legally compliant

Next Post

Dimensional Fund Advisors Cuts Mutual Fund Fees

Next Post
Dimensional Fund Advisors Cuts Mutual Fund Fees

Dimensional Fund Advisors Cuts Mutual Fund Fees

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News

Pa. Republicans reconsider Pitt funding over fetal tissue research, college voucher program

Arthur Pharma Closes Series A Financing Round

YouTube and the Achilles Tendon: An Analysis of Internet Information Reliability and Content Quality

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2022 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2022 researchsnappy.com